|
G |
AGT |
angiotensinogen |
multiple interactions |
ISO |
isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Hydrogen Peroxide]; isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Malondialdehyde]; isorhapontigenin inhibits the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]; isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:15607907 |
|
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
|
|
G |
CCND1 |
cyclin D1 |
decreases expression |
EXP |
isorhapontigenin results in decreased expression of CCND1 protein |
CTD |
PMID:37619952 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CDH1 |
cadherin 1 |
multiple interactions |
EXP |
[sodium bichromate co-treated with isorhapontigenin] results in increased expression of CDH1 protein |
CTD |
PMID:37619952 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CTNNB1 |
catenin beta 1 |
multiple interactions |
EXP |
[sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased localization of CTNNB1 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased phosphorylation of CTNNB1 protein |
CTD |
PMID:37619952 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT1 protein |
CTD |
PMID:37619952 |
|
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3A protein |
CTD |
PMID:37619952 |
|
NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
|
|
G |
DNMT3B |
DNA methyltransferase 3 beta |
multiple interactions |
EXP |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of DNMT3B protein |
CTD |
PMID:37619952 |
|
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
affects expression |
ISO |
isorhapontigenin affects the expression of FOS protein |
CTD |
PMID:15607907 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
[sodium bichromate co-treated with isorhapontigenin] results in increased phosphorylation of GSK3B protein |
CTD |
PMID:37619952 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
IKBKB |
inhibitor of nuclear factor kappa B kinase subunit beta |
affects activity |
ISO |
isorhapontigenin affects the activity of IKBKB protein |
CTD |
PMID:15607907 |
|
NCBI chr 8:42,271,302...42,332,460
Ensembl chr 8:42,271,302...42,332,460
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
affects expression |
ISO |
isorhapontigenin affects the expression of JUN protein |
CTD |
PMID:15607907 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO |
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:15607907 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
ISO |
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15607907 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
isorhapontigenin inhibits the reaction [AGT protein results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:15607907 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MEG3 |
maternally expressed 3 |
multiple interactions |
EXP |
isorhapontigenin inhibits the reaction [sodium bichromate results in decreased expression of MEG3] |
CTD |
PMID:37619952 |
|
NCBI chr14:100,826,108...100,861,026
Ensembl chr14:100,779,206...100,861,031
|
|
G |
MKI67 |
marker of proliferation Ki-67 |
decreases expression |
EXP |
isorhapontigenin results in decreased expression of MKI67 protein |
CTD |
PMID:37619952 |
|
NCBI chr10:128,096,659...128,126,423
Ensembl chr10:128,096,659...128,126,423
|
|
G |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
multiple interactions |
EXP |
[sodium bichromate co-treated with isorhapontigenin] inhibits the reaction [CTNNB1 protein modified form binds to NEDD9 protein]; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of and results in decreased localization of NEDD9 protein; [sodium bichromate co-treated with isorhapontigenin] results in decreased expression of NEDD9 mRNA |
CTD |
PMID:37619952 |
|
NCBI chr 6:11,183,298...11,382,348
Ensembl chr 6:11,183,298...11,382,348
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
isorhapontigenin affects the degradation of and affects the phosphorylation of NFKBIA protein |
CTD |
PMID:15607907 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
SNAI2 |
snail family transcriptional repressor 2 |
multiple interactions |
EXP |
[sodium bichromate co-treated with isorhapontigenin] results in decreased expression of SNAI2 protein |
CTD |
PMID:37619952 |
|
NCBI chr 8:48,917,598...48,921,429
Ensembl chr 8:48,917,598...48,921,740
|
|
|
G |
ABCG2 |
ATP binding cassette subfamily G member 2 (JR blood group) |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [potassium oxonate results in increased expression of ABCG2 protein] |
CTD |
PMID:22865646 |
|
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
|
|
G |
ACADM |
acyl-CoA dehydrogenase medium chain |
increases expression |
EXP |
pterostilbene results in increased expression of ACADM mRNA |
CTD |
PMID:26443543 |
|
NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,431...75,787,575
|
|
G |
ACOX1 |
acyl-CoA oxidase 1 |
multiple interactions |
ISO |
[Dietary Sucrose co-treated with Dietary Fats co-treated with pterostilbene] affects the activity of ACOX1 protein |
CTD |
PMID:25083823 |
|
NCBI chr17:75,941,507...75,979,166
Ensembl chr17:75,941,507...75,979,177
|
|
G |
AHR |
aryl hydrocarbon receptor |
increases activity multiple interactions |
EXP |
pterostilbene results in increased activity of AHR protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [pterostilbene results in increased activity of AHR protein]; pterostilbene inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:28279696 PMID:31004704 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
AKR1B1 |
aldo-keto reductase family 1 member B |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Azoxymethane results in increased expression of AKR1B1 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of AKR1B1 protein] |
CTD |
PMID:21355597 |
|
NCBI chr 7:134,442,350...134,459,239
Ensembl chr 7:134,442,356...134,459,284
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
decreases expression increases phosphorylation multiple interactions |
EXP |
pterostilbene results in decreased expression of AKT1 mRNA pterostilbene results in increased phosphorylation of AKT1 protein pterostilbene results in decreased phosphorylation of and results in decreased activity of AKT1 protein |
CTD |
PMID:20152895 PMID:24154491 PMID:31139082 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
|
|
G |
AMACR |
alpha-methylacyl-CoA racemase |
decreases expression |
EXP |
pterostilbene results in decreased expression of AMACR mRNA |
CTD |
PMID:20152895 |
|
NCBI chr 5:33,986,165...34,008,050
Ensembl chr 5:33,986,165...34,008,104
|
|
G |
ATF2 |
activating transcription factor 2 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ATF2 protein modified form] |
CTD |
PMID:19549798 |
|
NCBI chr 2:175,072,259...175,168,203
Ensembl chr 2:175,072,250...175,168,382
|
|
G |
ATG5 |
autophagy related 5 |
multiple interactions |
ISO EXP |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]] |
CTD |
PMID:34405320 |
|
NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791
|
|
G |
ATG7 |
autophagy related 7 |
multiple interactions |
EXP |
ATG7 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]] |
CTD |
PMID:34405320 |
|
NCBI chr 3:11,272,397...11,576,353
Ensembl chr 3:11,272,309...11,557,665
|
|
G |
BAD |
BCL2 associated agonist of cell death |
increases expression multiple interactions |
ISO EXP |
pterostilbene results in increased expression of BAD protein pterostilbene inhibits the reaction [sodium arsenite results in increased expression of BAD protein] |
CTD |
PMID:20681671 PMID:31139082 |
|
NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
|
|
G |
BAK1 |
BCL2 antagonist/killer 1 |
increases expression |
EXP |
pterostilbene results in increased expression of BAK1 protein |
CTD |
PMID:23313376 |
|
NCBI chr 6:33,572,552...33,580,276
Ensembl chr 6:33,572,547...33,580,293
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
affects response to substance multiple interactions increases expression |
EXP ISO |
BAX protein affects the susceptibility to pterostilbene pterostilbene inhibits the reaction [sodium arsenite results in increased expression of BAX protein] pterostilbene results in increased expression of BAX mRNA; pterostilbene results in increased expression of BAX protein |
CTD |
PMID:20152895 PMID:20681671 PMID:22572619 PMID:23313376 PMID:24936659 PMID:31139082 More...
|
|
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions decreases expression increases expression |
EXP ISO |
[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein; pterostilbene inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]; RELA protein affects the reaction [[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein] pterostilbene results in decreased expression of BCL2 mRNA; pterostilbene results in decreased expression of BCL2 protein pterostilbene results in increased expression of BCL2 protein |
CTD |
PMID:18852136 PMID:20152895 PMID:20681671 PMID:24936659 PMID:31139082 |
|
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
|
|
G |
BCL2L1 |
BCL2 like 1 |
increases expression multiple interactions decreases expression |
ISO EXP |
pterostilbene results in increased expression of BCL2L1 protein pterostilbene inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein] pterostilbene results in decreased expression of BCL2L1 protein |
CTD |
PMID:20681671 PMID:23313376 PMID:31139082 |
|
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
|
|
G |
BECN1 |
beclin 1 |
multiple interactions |
ISO EXP |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]] BECN1 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]] |
CTD |
PMID:34405320 |
|
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
|
|
G |
BID |
BH3 interacting domain death agonist |
increases expression |
ISO |
pterostilbene results in increased expression of BID protein modified form |
CTD |
PMID:20681671 |
|
NCBI chr22:17,734,138...17,774,665
Ensembl chr22:17,734,138...17,774,770
|
|
G |
CAMP |
cathelicidin antimicrobial peptide |
multiple interactions increases expression |
EXP |
calcipotriene promotes the reaction [pterostilbene results in increased expression of CAMP mRNA]; Calcitriol promotes the reaction [pterostilbene results in increased expression of CAMP mRNA]; Calcitriol promotes the reaction [pterostilbene results in increased expression of CAMP protein]; paricalcitol promotes the reaction [pterostilbene results in increased expression of CAMP mRNA]; pterostilbene promotes the reaction [Calcitriol results in increased expression of CAMP mRNA]; pterostilbene promotes the reaction [Calcitriol results in increased expression of CAMP protein] pterostilbene results in increased expression of CAMP mRNA; pterostilbene results in increased expression of CAMP protein |
CTD |
PMID:24039193 |
|
NCBI chr 3:48,223,495...48,225,485
Ensembl chr 3:48,223,347...48,225,491
|
|
G |
CASP1 |
caspase 1 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Ethanol results in increased expression of CASP1 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CASP1 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr11:105,025,443...105,036,686
Ensembl chr11:105,025,397...105,035,250
|
|
G |
CASP3 |
caspase 3 |
increases cleavage increases expression increases activity multiple interactions |
ISO EXP |
pterostilbene results in increased cleavage of CASP3 protein pterostilbene results in increased expression of CASP3 mRNA pterostilbene results in increased activity of CASP3 protein 2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased activity of CASP3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP3 protein]; pterostilbene inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP3 protein] |
CTD |
PMID:20152895 PMID:20681671 PMID:23313376 PMID:24936659 PMID:25341683 PMID:31139082 PMID:33930484 More...
|
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CASP4 |
caspase 4 |
multiple interactions increases activity |
EXP |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased activity of CASP4 protein]; CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP4 protein] |
CTD |
PMID:25341683 |
|
NCBI chr11:104,942,866...104,968,574
Ensembl chr11:104,942,866...104,969,366
|
|
G |
CASP7 |
caspase 7 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP7 protein] |
CTD |
PMID:33930484 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP8 |
caspase 8 |
multiple interactions |
ISO |
pterostilbene results in increased cleavage of and results in increased activity of CASP8 protein |
CTD |
PMID:20681671 |
|
NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
|
|
G |
CASP9 |
caspase 9 |
increases expression multiple interactions increases activity increases cleavage |
EXP ISO |
pterostilbene results in increased expression of CASP9 protein pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of CASP9 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased activity of CASP9 protein] pterostilbene results in increased cleavage of CASP9 protein |
CTD |
PMID:20152895 PMID:20681671 PMID:25341683 PMID:33930484 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions increases expression |
EXP ISO |
CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased activity of CASP4 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; pterostilbene inhibits the reaction [Ethanol results in decreased activity of CAT protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased activity of CAT protein]] pterostilbene inhibits the reaction [Streptozocin results in decreased expression of CAT] pterostilbene results in increased expression of CAT mRNA |
CTD |
PMID:25341683 PMID:26700463 PMID:34474091 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCN1 |
cellular communication network factor 1 |
multiple interactions |
ISO EXP |
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1A mRNA]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein] 3-methyladenine inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; Ammonium Chloride inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; ATG7 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; BECN1 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]]; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; Chloroquine inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CCN1 protein] |
CTD |
PMID:34405320 |
|
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
|
|
G |
CCND1 |
cyclin D1 |
decreases expression multiple interactions |
EXP ISO |
pterostilbene results in decreased expression of CCND1 protein pterostilbene inhibits the reaction [Azoxymethane results in increased expression of CCND1 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of CCND1 protein] |
CTD |
PMID:19549798 PMID:20398797 PMID:20681671 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCNE1 |
cyclin E1 |
decreases expression |
ISO |
pterostilbene results in decreased expression of CCNE1 protein |
CTD |
PMID:20398797 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
|
|
G |
CDH1 |
cadherin 1 |
multiple interactions increases expression |
ISO EXP |
pterostilbene inhibits the reaction [Azoxymethane results in decreased expression of CDH1 protein] pterostilbene results in increased expression of CDH1 protein |
CTD |
PMID:20681671 PMID:23921149 |
|
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
|
|
G |
CDK2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
pterostilbene results in decreased expression of CDK2 protein |
CTD |
PMID:20398797 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
G |
CDK4 |
cyclin dependent kinase 4 |
decreases expression |
ISO |
pterostilbene results in decreased expression of CDK4 protein |
CTD |
PMID:20398797 |
|
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression multiple interactions |
EXP ISO |
pterostilbene results in increased expression of CDKN1A protein CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN1A protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN1A protein]] |
CTD |
PMID:23313376 PMID:34405320 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CDKN1B |
cyclin dependent kinase inhibitor 1B |
increases expression |
EXP |
pterostilbene results in increased expression of CDKN1B protein |
CTD |
PMID:23313376 |
|
NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
|
|
G |
CDKN2A |
cyclin dependent kinase inhibitor 2A |
multiple interactions |
EXP ISO |
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of CDKN2A protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN2A protein]] |
CTD |
PMID:34405320 |
|
NCBI chr 9:21,967,752...21,995,324
Ensembl chr 9:21,967,752...21,995,301
|
|
G |
CPT1A |
carnitine palmitoyltransferase 1A |
multiple interactions |
ISO |
[Dietary Sucrose co-treated with Dietary Fats co-treated with pterostilbene] affects the activity of CPT1A protein |
CTD |
PMID:25083823 |
|
NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
|
|
G |
CRP |
C-reactive protein |
multiple interactions |
EXP |
[resveratrol co-treated with pterostilbene co-treated with Quercetin co-treated with tocotrienol, delta co-treated with Niacin] results in decreased expression of CRP protein |
CTD |
PMID:24319627 |
|
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
|
|
G |
CXCL3 |
C-X-C motif chemokine ligand 3 |
increases expression |
EXP |
pterostilbene results in increased expression of CXCL3 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr 4:74,036,589...74,038,689
Ensembl chr 4:74,036,589...74,038,807
|
|
G |
CYCS |
cytochrome c, somatic |
affects localization increases expression |
EXP |
pterostilbene affects the localization of CYCS protein pterostilbene results in increased expression of CYCS mRNA; pterostilbene results in increased expression of CYCS protein |
CTD |
PMID:22450950 PMID:22572619 PMID:26443543 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP1A1 |
cytochrome P450 family 1 subfamily A member 1 |
decreases expression multiple interactions increases expression |
EXP |
pterostilbene results in decreased expression of CYP1A1 mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [pterostilbene results in increased expression of CYP1A1 protein] |
CTD |
PMID:22450950 PMID:31004704 |
|
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
decreases activity |
ISO EXP |
pterostilbene results in decreased activity of CYP1A2 protein |
CTD |
PMID:16684708 PMID:30394306 |
|
NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
|
|
G |
CYP2B6 |
cytochrome P450 family 2 subfamily B member 6 |
increases expression |
EXP |
pterostilbene results in increased expression of CYP2B6 mRNA |
CTD |
PMID:30394306 |
|
NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
|
|
G |
CYP2C19 |
cytochrome P450 family 2 subfamily C member 19 |
decreases activity |
EXP |
pterostilbene results in decreased activity of CYP2C19 protein |
CTD |
PMID:30394306 |
|
NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions increases expression |
EXP |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of DDIT3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of DDIT3 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased expression of DDIT3 protein] pterostilbene results in increased expression of DDIT3 mRNA; pterostilbene results in increased expression of DDIT3 protein |
CTD |
PMID:22450950 PMID:25341683 |
|
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
|
|
G |
DFFA |
DNA fragmentation factor subunit alpha |
increases cleavage |
ISO |
pterostilbene results in increased cleavage of DFFA protein |
CTD |
PMID:20681671 |
|
NCBI chr 1:10,456,522...10,472,529
Ensembl chr 1:10,456,522...10,472,529
|
|
G |
DHRS2 |
dehydrogenase/reductase 2 |
increases expression |
EXP |
pterostilbene results in increased expression of DHRS2 mRNA; pterostilbene results in increased expression of DHRS2 protein |
CTD |
PMID:24936659 |
|
NCBI chr14:23,630,115...23,645,639
Ensembl chr14:23,630,115...23,645,639
|
|
G |
DIABLO |
diablo IAP-binding mitochondrial protein |
increases expression affects localization |
EXP |
pterostilbene results in increased expression of DIABLO protein pterostilbene affects the localization of DIABLO protein |
CTD |
PMID:22450950 PMID:22572619 |
|
NCBI chr12:122,207,662...122,227,456
Ensembl chr12:122,207,668...122,226,062
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
[resveratrol co-treated with pterostilbene] results in decreased expression of DNMT1 mRNA |
CTD |
PMID:26459286 |
|
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[resveratrol co-treated with pterostilbene] results in decreased expression of DNMT3A mRNA |
CTD |
PMID:26459286 |
|
NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
|
|
G |
DNMT3B |
DNA methyltransferase 3 beta |
multiple interactions |
EXP |
pterostilbene promotes the reaction [resveratrol results in decreased expression of DNMT3B mRNA] |
CTD |
PMID:26459286 |
|
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
|
|
G |
EGF |
epidermal growth factor |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGF protein] |
CTD |
PMID:19447859 |
|
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGFR protein] |
CTD |
PMID:19447859 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EIF2A |
eukaryotic translation initiation factor 2A |
increases phosphorylation |
EXP |
pterostilbene results in increased phosphorylation of EIF2A protein |
CTD |
PMID:25341683 |
|
NCBI chr 3:150,546,787...150,586,016
Ensembl chr 3:150,546,678...150,586,016
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions increases phosphorylation |
EXP |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased phosphorylation of EIF2AK3 protein] |
CTD |
PMID:25341683 |
|
NCBI chr 2:88,556,741...88,628,145
Ensembl chr 2:88,556,741...88,691,518
|
|
G |
ELK1 |
ETS transcription factor ELK1 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ELK1 protein modified form] |
CTD |
PMID:19549798 |
|
NCBI chr X:47,635,520...47,650,604
Ensembl chr X:47,635,520...47,650,604
|
|
G |
ESR1 |
estrogen receptor 1 |
increases expression multiple interactions |
EXP |
pterostilbene results in increased expression of ESR1 protein [resveratrol co-treated with pterostilbene] results in increased expression of ESR1 mRNA; [resveratrol co-treated with pterostilbene] results in increased expression of ESR1 protein |
CTD |
PMID:27159275 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ESR2 |
estrogen receptor 2 |
multiple interactions |
ISO |
ESR2 gene mutant form inhibits the reaction [pterostilbene results in increased expression of SOD2 protein] |
CTD |
PMID:24361291 |
|
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
|
|
G |
FAS |
Fas cell surface death receptor |
increases expression |
ISO |
pterostilbene results in increased expression of FAS protein |
CTD |
PMID:20681671 |
|
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
|
|
G |
FASLG |
Fas ligand |
increases expression |
ISO |
pterostilbene results in increased expression of FASL protein |
CTD |
PMID:20681671 |
|
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
|
|
G |
FASN |
fatty acid synthase |
multiple interactions |
ISO |
[Dietary Sucrose co-treated with Dietary Fats co-treated with pterostilbene] affects the activity of FASN protein |
CTD |
PMID:25083823 |
|
NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein]]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of FOS protein] |
CTD |
PMID:18551458 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
FUT1 |
fucosyltransferase 1 (H blood group) |
increases expression |
EXP |
pterostilbene results in increased expression of FUT1 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr19:48,748,011...48,755,358
Ensembl chr19:48,748,011...48,755,390
|
|
G |
GDF15 |
growth differentiation factor 15 |
increases expression |
EXP |
pterostilbene results in increased expression of GDF15 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
|
|
G |
GLO1 |
glyoxalase I |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of GLO1 protein] |
CTD |
PMID:33930484 |
|
NCBI chr 6:38,675,925...38,703,145
Ensembl chr 6:38,675,925...38,703,145
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions increases expression |
EXP |
Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of GPX1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased expression of GPX1 mRNA] |
CTD |
PMID:25341683 |
|
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
|
|
G |
GSK3B |
glycogen synthase kinase 3 beta |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:20681671 |
|
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions decreases expression |
ISO EXP |
NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]]; pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA] pterostilbene results in decreased expression of GSR mRNA |
CTD |
PMID:21355597 PMID:25341683 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
H2AX |
H2A.X variant histone |
multiple interactions |
EXP ISO |
[Resveratrol co-treated with pterostilbene] results in decreased expression of H2AX protein modified form; CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of H2AX protein modified form]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of H2AX protein modified form]] |
CTD |
PMID:26459286 PMID:34405320 |
|
NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
|
|
G |
HDAC5 |
histone deacetylase 5 |
multiple interactions increases phosphorylation |
EXP |
HDAC5 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of HDAC5 protein]; pterostilbene inhibits the reaction [HDAC5 protein binds to SOD2 promoter] |
CTD |
PMID:26443543 |
|
NCBI chr17:44,076,753...44,123,641
Ensembl chr17:44,076,746...44,123,702
|
|
G |
HMGA1 |
high mobility group AT-hook 1 |
multiple interactions |
EXP ISO |
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased secretion of HMGA1 protein]; pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMGA1 protein]] CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of HMGA1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMGA1 protein]] |
CTD |
PMID:34405320 PMID:34474091 |
|
NCBI chr 6:34,236,873...34,246,231
Ensembl chr 6:34,236,873...34,246,231
|
|
G |
HMGB1 |
high mobility group box 1 |
multiple interactions |
EXP |
NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of HMGB1 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
|
|
G |
HMOX1 |
heme oxygenase 1 |
increases expression multiple interactions |
EXP ISO |
pterostilbene results in increased expression of HMOX1 mRNA; pterostilbene results in increased expression of HMOX1 protein [pterostilbene co-treated with kaempferol] results in increased expression of HMOX1 mRNA; pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMOX1 protein]; pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of HMOX1 mRNA]; pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of HMOX1 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMOX1 protein]] NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]]; pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]; pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 protein] |
CTD |
PMID:21355597 PMID:22450950 PMID:25111660 PMID:31139082 PMID:33930484 PMID:34474091 More...
|
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
HNRNPM |
heterogeneous nuclear ribonucleoprotein M |
increases expression |
EXP |
pterostilbene results in increased expression of HNRNPM mRNA |
CTD |
PMID:22450950 |
|
NCBI chr19:8,444,975...8,489,114
Ensembl chr19:8,444,767...8,489,114
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions increases expression |
EXP |
2-tert-butylhydroquinone inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of HSPA5 protein]; CAT protein inhibits the reaction [pterostilbene results in increased expression of HSPA5 protein]; Thapsigargin promotes the reaction [pterostilbene results in increased expression of HSPA5 protein] pterostilbene results in increased expression of HSPA5 mRNA; pterostilbene results in increased expression of HSPA5 protein |
CTD |
PMID:25341683 |
|
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
|
|
G |
HSPA9 |
heat shock protein family A (Hsp70) member 9 |
increases expression |
EXP |
pterostilbene results in increased expression of HSPA9 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr 5:138,553,756...138,575,401
Ensembl chr 5:138,553,756...138,575,675
|
|
G |
HSPE1 |
heat shock protein family E (Hsp10) member 1 |
decreases expression |
EXP |
pterostilbene results in decreased expression of HSPE1 protein |
CTD |
PMID:24936659 |
|
NCBI chr 2:197,500,379...197,503,449
Ensembl chr 2:197,500,140...197,503,449
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
EXP ISO |
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]]; pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ATF2 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ELK1 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IFNG protein] pterostilbene inhibits the reaction [Ethanol results in increased secretion of IFNG protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IFNG protein]] |
CTD |
PMID:19549798 PMID:22698256 PMID:34405320 PMID:34474091 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL18 |
interleukin 18 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Ethanol results in increased expression of IL18 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL18 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
|
|
G |
IL1A |
interleukin 1 alpha |
multiple interactions |
EXP ISO |
NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IL1A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased secretion of IL1A protein] CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1A mRNA]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1A mRNA] |
CTD |
PMID:34405320 PMID:34474091 |
|
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
EXP ISO |
pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1B protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1B protein]] pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:19549798 PMID:22698256 PMID:34474091 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO EXP |
CCN1 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]]; pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL6 mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased secretion of IL6 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]] |
CTD |
PMID:22698256 PMID:34405320 PMID:34474091 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Streptozocin results in decreased secretion of INS1 protein] |
CTD |
PMID:26700463 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
ITGB8 |
integrin subunit beta 8 |
decreases expression increases expression |
EXP |
pterostilbene results in decreased expression of ITGB8 mRNA pterostilbene results in increased expression of ITGB8 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr 7:20,329,766...20,415,754
Ensembl chr 7:20,330,702...20,415,754
|
|
G |
JAK2 |
Janus kinase 2 |
decreases phosphorylation |
EXP |
pterostilbene results in decreased phosphorylation of JAK2 protein |
CTD |
PMID:23313376 |
|
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of [JUN protein binds to FOS protein]]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of JUN protein] |
CTD |
PMID:18551458 |
|
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [NFE2L2 protein binds to KEAP1 protein] |
CTD |
PMID:26700463 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
KLF2 |
KLF transcription factor 2 |
multiple interactions increases expression |
EXP |
MAPK7 protein affects the reaction [pterostilbene results in increased expression of KLF2 mRNA]; pterostilbene promotes the reaction [KLF2 protein binds to SOD2 promoter] pterostilbene results in increased expression of KLF2 mRNA; pterostilbene results in increased expression of KLF2 protein |
CTD |
PMID:26443543 |
|
NCBI chr19:16,324,826...16,328,685
Ensembl chr19:16,324,826...16,328,685
|
|
G |
LAMP1 |
lysosomal associated membrane protein 1 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of LAMP1 protein] |
CTD |
PMID:34405320 |
|
NCBI chr13:113,297,239...113,323,672
Ensembl chr13:113,297,239...113,323,672
|
|
G |
LDLR |
low density lipoprotein receptor |
decreases expression |
EXP |
pterostilbene results in decreased expression of LDLR mRNA |
CTD |
PMID:22153697 |
|
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
|
|
G |
MAP1LC3B |
microtubule associated protein 1 light chain 3 beta |
multiple interactions |
EXP ISO |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]] |
CTD |
PMID:34405320 |
|
NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions decreases phosphorylation |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [pterostilbene results in increased phosphorylation of MAPK1 protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein]; pterostilbene results in increased phosphorylation of and results in increased activity of MAPK1 protein pterostilbene results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:19447859 PMID:24154491 PMID:26138072 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
multiple interactions |
EXP |
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]] |
CTD |
PMID:19549798 |
|
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,752...36,122,511
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions decreases phosphorylation |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [pterostilbene results in increased phosphorylation of MAPK3 protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein]; pterostilbene results in increased phosphorylation of and results in increased activity of MAPK3 protein pterostilbene results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:19447859 PMID:24154491 PMID:26138072 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAPK7 |
mitogen-activated protein kinase 7 |
multiple interactions increases phosphorylation |
EXP |
MAPK7 protein affects the reaction [pterostilbene results in increased expression of KLF2 mRNA]; MAPK7 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of MAPK7 protein] |
CTD |
PMID:26443543 |
|
NCBI chr17:19,377,750...19,383,544
Ensembl chr17:19,377,721...19,383,544
|
|
G |
MAPK8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK8 protein]; pterostilbene results in decreased phosphorylation of and results in decreased activity of MAPK8 protein |
CTD |
PMID:19447859 PMID:24154491 |
|
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
|
|
G |
MAPK9 |
mitogen-activated protein kinase 9 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK9 protein]; pterostilbene results in decreased phosphorylation of and results in decreased activity of MAPK9 protein |
CTD |
PMID:19447859 PMID:24154491 |
|
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
|
|
G |
MCL1 |
MCL1 apoptosis regulator, BCL2 family member |
decreases expression |
EXP |
pterostilbene results in decreased expression of MCL1 protein |
CTD |
PMID:23313376 |
|
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
|
|
G |
MLKL |
mixed lineage kinase domain like pseudokinase |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Ethanol results in increased phosphorylation of MLKL protein] |
CTD |
PMID:34474091 |
|
NCBI chr16:74,671,855...74,700,862
Ensembl chr16:74,671,855...74,700,960
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP2 protein] |
CTD |
PMID:20681671 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP28 |
matrix metallopeptidase 28 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Azoxymethane results in increased activity of MMP26 protein] |
CTD |
PMID:20681671 |
|
NCBI chr17:35,756,249...35,795,641
Ensembl chr17:35,756,249...35,795,707
|
|
G |
MMP7 |
matrix metallopeptidase 7 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Azoxymethane results in increased activity of MMP7 protein]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of MMP7 mRNA]; pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP2 protein]; pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP9 protein] |
CTD |
PMID:20681671 |
|
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
decreases expression decreases activity multiple interactions |
EXP ISO |
pterostilbene results in decreased expression of MMP9 mRNA pterostilbene results in decreased activity of MMP9 protein pterostilbene inhibits the reaction [MMP7 protein results in increased activity of MMP9 protein] pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and results in increased activity of MMP9 protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA] |
CTD |
PMID:19447859 PMID:19617202 PMID:20152895 PMID:20681671 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
EXP |
pterostilbene results in decreased expression of MYC protein |
CTD |
PMID:19549798 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
NFATC4 |
nuclear factor of activated T cells 4 |
multiple interactions |
EXP |
NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK1 protein]]; NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA]]; NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of HMGB1 protein]]; NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IL1A protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased acetylation of NFATC4 protein]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased acetylation of NFATC4 protein]]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NFATC4 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr14:24,366,911...24,379,604
Ensembl chr14:24,365,673...24,379,604
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions affects localization increases expression increases phosphorylation |
ISO EXP |
NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of GSR mRNA]]; NFE2L2 protein promotes the reaction [pterostilbene promotes the reaction [Azoxymethane results in increased expression of HMOX1 mRNA]]; pterostilbene inhibits the reaction [NFE2L2 protein binds to KEAP1 protein]; pterostilbene inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein]; pterostilbene inhibits the reaction [Streptozocin results in decreased phosphorylation of and affects the localization of NFE2L2 protein]; pterostilbene results in increased expression of and results in increased localization of NFE2L2 protein; pterostilbene results in increased phosphorylation of and affects the localization of NFE2L2 protein pterostilbene affects the localization of NFE2L2 protein pterostilbene results in increased expression of NFE2L2 protein pterostilbene results in increased phosphorylation of NFE2L2 protein 2-tert-butylhydroquinone promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; Acetylcysteine inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; CAT protein inhibits the reaction [pterostilbene results in increased phosphorylation of NFE2L2 protein]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein]; pterostilbene inhibits the reaction [Pyruvaldehyde affects the localization of NFE2L2 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein]] |
CTD |
PMID:21355597 PMID:25341683 PMID:26700463 PMID:31139082 PMID:33930484 PMID:34474091 More...
|
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
[pterostilbene co-treated with Quercetin] results in decreased activity of [NFKB1 protein binds to RELA protein] |
CTD |
PMID:18852136 |
|
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
EXP ISO |
[pterostilbene co-treated with Quercetin] results in decreased degradation of NFKBIA protein; [pterostilbene co-treated with Quercetin] results in decreased phosphorylation of NFKBIA protein pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NFKBIA protein] |
CTD |
PMID:18551458 PMID:18852136 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Ethanol results in increased expression of NLRP3 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NLRP3 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,332,331...247,449,108
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
EXP ISO |
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein] pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of NOS2 protein] |
CTD |
PMID:18551458 PMID:19549798 PMID:20681671 PMID:21355597 PMID:22698256 PMID:22842666 PMID:23731018 More...
|
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions |
EXP |
pterostilbene results in increased expression of NQO1 mRNA; pterostilbene results in increased expression of NQO1 protein [pterostilbene co-treated with kaempferol] results in increased expression of NQO1 protein; [pterostilbene co-treated with Quercetin] results in increased expression of NQO1 protein; Acetylcysteine inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; Buthionine Sulfoximine promotes the reaction [pterostilbene results in increased expression of NQO1 mRNA]; CAT protein inhibits the reaction [pterostilbene results in increased expression of NQO1 mRNA]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of NQO1 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NQO1 protein]] |
CTD |
PMID:25111660 PMID:25341683 PMID:31139082 PMID:34474091 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
NQO2 |
N-ribosyldihydronicotinamide:quinone dehydrogenase 2 |
increases expression |
EXP |
pterostilbene results in increased expression of NQO2 mRNA; pterostilbene results in increased expression of NQO2 protein |
CTD |
PMID:24936659 |
|
NCBI chr 6:2,999,894...3,019,755
Ensembl chr 6:2,987,987...3,019,755
|
|
G |
NR1I2 |
nuclear receptor subfamily 1 group I member 2 |
multiple interactions affects binding |
EXP |
pterostilbene binds to and results in increased activity of NR1I2 protein pterostilbene binds to NR1I2 protein |
CTD |
PMID:20869355 PMID:30394306 |
|
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
|
|
G |
NR1I3 |
nuclear receptor subfamily 1 group I member 3 |
multiple interactions |
EXP |
pterostilbene binds to and results in increased activity of NR1I3 protein alternative form |
CTD |
PMID:20869355 |
|
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
increases expression multiple interactions |
EXP |
pterostilbene results in increased expression of PARP1 protein modified form pterostilbene inhibits the reaction [Pyruvaldehyde results in increased cleavage of PARP1 protein] |
CTD |
PMID:19549798 PMID:33930484 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PCNA |
proliferating cell nuclear antigen |
decreases expression |
ISO |
pterostilbene results in decreased expression of PCNA protein |
CTD |
PMID:20398797 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
PDK4 |
pyruvate dehydrogenase kinase 4 |
increases expression |
EXP |
pterostilbene results in increased expression of PDK4 mRNA |
CTD |
PMID:26443543 |
|
NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,499...95,596,516
|
|
G |
PGAM1 |
phosphoglycerate mutase 1 |
decreases expression |
EXP |
pterostilbene results in decreased expression of PGAM1 protein |
CTD |
PMID:24936659 |
|
NCBI chr10:97,426,191...97,433,444
Ensembl chr10:97,426,191...97,433,444
|
|
G |
PGR |
progesterone receptor |
multiple interactions |
EXP |
[resveratrol co-treated with pterostilbene] promotes the reaction [afimoxifene results in decreased expression of PGR mRNA]; [resveratrol co-treated with pterostilbene] promotes the reaction [Estradiol results in increased expression of PGR mRNA] |
CTD |
PMID:27159275 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO EXP |
pterostilbene binds to and results in increased activity of PPARA protein pterostilbene inhibits the reaction [Ethanol results in decreased expression of PPARA protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of PPARA protein]] |
CTD |
PMID:15853379 PMID:34474091 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
increases expression |
EXP |
pterostilbene results in increased expression of PPARGC1A mRNA |
CTD |
PMID:26443543 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions increases phosphorylation |
EXP |
PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of HDAC5 protein]; PRKAA1 protein affects the reaction [pterostilbene results in increased phosphorylation of MAPK7 protein] pterostilbene results in increased phosphorylation of PRKAA1 protein |
CTD |
PMID:26443543 |
|
NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
|
|
G |
PRKCB |
protein kinase C beta |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of and results in increased activity of PRKCB protein] |
CTD |
PMID:21355597 |
|
NCBI chr16:23,835,983...24,220,611
Ensembl chr16:23,835,983...24,220,611
|
|
G |
PSME3 |
proteasome activator subunit 3 |
decreases expression |
EXP |
pterostilbene results in decreased expression of PSME3 protein |
CTD |
PMID:24936659 |
|
NCBI chr17:42,833,397...42,843,760
Ensembl chr17:42,824,385...42,843,760
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP ISO |
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein] pterostilbene inhibits the reaction [Azoxymethane results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [Azoxymethane results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of PTGS2 protein] |
CTD |
PMID:18551458 PMID:19549798 PMID:20681671 PMID:21355597 PMID:22842666 PMID:23731018 More...
|
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
PYCARD |
PYD and CARD domain containing |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Ethanol results in increased expression of PYCARD protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of PYCARD protein]] |
CTD |
PMID:34474091 |
|
NCBI chr16:31,201,486...31,202,760
Ensembl chr16:31,201,486...31,203,450
|
|
G |
RB1 |
RB transcriptional corepressor 1 |
decreases expression |
ISO |
pterostilbene results in decreased expression of RB1 protein |
CTD |
PMID:20398797 |
|
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP ISO |
[pterostilbene co-treated with Quercetin] affects the localization of RELA protein; [pterostilbene co-treated with Quercetin] results in decreased activity of [NFKB1 protein binds to RELA protein]; RELA protein affects the reaction [[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein] pterostilbene inhibits the reaction [Azoxymethane results in increased phosphorylation of RELA protein]; pterostilbene inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of RELA protein] |
CTD |
PMID:18551458 PMID:18852136 PMID:21355597 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RIPK1 |
receptor interacting serine/threonine kinase 1 |
multiple interactions |
EXP |
NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK1 protein]]; pterostilbene inhibits the reaction [Ethanol promotes the reaction [RIPK1 protein binds to RIPK3 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK1 protein] |
CTD |
PMID:34474091 |
|
NCBI chr 6:3,063,967...3,115,187
Ensembl chr 6:3,063,824...3,115,187
|
|
G |
RIPK3 |
receptor interacting serine/threonine kinase 3 |
multiple interactions |
EXP |
NFATC4 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA]]; pterostilbene inhibits the reaction [Ethanol promotes the reaction [RIPK1 protein binds to RIPK3 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased expression of RIPK3 protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased activity of CAT protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMOX1 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NFE2L2 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of NQO1 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of PPARA protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of CASP1 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL18 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL1B protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of IL6 mRNA]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NLRP3 protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of PYCARD protein]]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of TNF mRNA]] |
CTD |
PMID:34474091 |
|
NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
|
|
G |
RPS12 |
ribosomal protein S12 |
decreases expression |
EXP |
pterostilbene results in decreased expression of RPS12 protein |
CTD |
PMID:24936659 |
|
NCBI chr 6:132,814,569...132,817,564
Ensembl chr 6:132,814,569...132,817,564
|
|
G |
SARS1 |
seryl-tRNA synthetase 1 |
increases expression |
EXP |
pterostilbene results in increased expression of SARS1 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr 1:109,213,893...109,238,182
Ensembl chr 1:109,213,918...109,238,182
|
|
G |
SESN2 |
sestrin 2 |
multiple interactions |
EXP ISO |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of SESN2 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN1A protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN2A protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of H2AX protein modified form]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMGA1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of SESN2 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]] pterostilbene inhibits the reaction [Ethanol results in decreased expression of SESN2 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of ATG5 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of BECN1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN1A protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of CDKN2A protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of H2AX protein modified form]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of HMGA1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of MAP1LC3B protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in decreased expression of SESN2 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of IFNG protein]]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]] |
CTD |
PMID:34405320 |
|
NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
|
|
G |
SIRT1 |
sirtuin 1 |
multiple interactions |
EXP |
[resveratrol co-treated with pterostilbene] results in decreased expression of SIRT1 mRNA; [resveratrol co-treated with pterostilbene] results in decreased expression of SIRT1 protein |
CTD |
PMID:26459286 |
|
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
|
|
G |
SIRT2 |
sirtuin 2 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Ethanol results in decreased expression of SIRT2 protein]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of and results in increased acetylation of NFATC4 protein]]; SIRT2 protein affects the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of NFATC4 protein]] |
CTD |
PMID:34474091 |
|
NCBI chr19:38,878,555...38,899,618
Ensembl chr19:38,878,555...38,899,862
|
|
G |
SLC22A12 |
solute carrier family 22 member 12 |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [potassium oxonate results in increased expression of SLC22A12 protein] |
CTD |
PMID:22865646 |
|
NCBI chr11:64,591,220...64,602,344
Ensembl chr11:64,590,641...64,602,353
|
|
G |
SNAI1 |
snail family transcriptional repressor 1 |
decreases expression |
EXP |
pterostilbene results in decreased expression of SNAI1 protein |
CTD |
PMID:23921149 |
|
NCBI chr20:49,982,980...49,988,886
Ensembl chr20:49,982,980...49,988,886
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions increases expression |
EXP |
[pterostilbene co-treated with kaempferol] results in increased expression of SOD1 protein; [pterostilbene co-treated with Quercetin] results in increased expression of SOD1 protein; pterostilbene inhibits the reaction [Pyruvaldehyde results in decreased expression of SOD1 mRNA] pterostilbene results in increased expression of SOD1 protein |
CTD |
PMID:25111660 PMID:33930484 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions increases expression increases activity |
EXP ISO |
[pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein; HDAC5 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; MAPK7 protein affects the reaction [pterostilbene results in increased expression of SOD2 mRNA]; pterostilbene inhibits the reaction [HDAC5 protein binds to SOD2 promoter]; pterostilbene promotes the reaction [KLF2 protein binds to SOD2 promoter]; pterostilbene results in increased expression of and results in increased activity of SOD2 protein; SP1 protein affects the reaction [[pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein] pterostilbene results in increased expression of SOD2 protein ESR2 gene mutant form inhibits the reaction [pterostilbene results in increased expression of SOD2 protein]; fulvestrant inhibits the reaction [pterostilbene results in increased expression of SOD2 protein] pterostilbene results in increased activity of SOD2 protein |
CTD |
PMID:18852136 PMID:22450950 PMID:22572619 PMID:24361291 PMID:26443543 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SP1 |
Sp1 transcription factor |
multiple interactions |
EXP |
SP1 protein affects the reaction [[pterostilbene co-treated with Quercetin] results in increased expression of SOD2 protein] |
CTD |
PMID:18852136 |
|
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
|
|
G |
SQSTM1 |
sequestosome 1 |
multiple interactions |
ISO EXP |
pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]] bafilomycin A1 inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]]; Cycloheximide promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]]; pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of SQSTM1 protein]] |
CTD |
PMID:34405320 |
|
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
|
|
G |
STAT3 |
signal transducer and activator of transcription 3 |
decreases expression decreases phosphorylation decreases activity |
EXP ISO |
pterostilbene results in decreased expression of STAT3 protein modified form pterostilbene results in decreased phosphorylation of STAT3 protein pterostilbene results in decreased activity of STAT3 protein |
CTD |
PMID:22450950 PMID:23313376 PMID:26138072 |
|
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
|
|
G |
STK11 |
serine/threonine kinase 11 |
increases phosphorylation |
EXP |
pterostilbene results in increased phosphorylation of STK11 protein |
CTD |
PMID:26443543 |
|
NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431
|
|
G |
TERF1 |
telomeric repeat binding factor 1 |
multiple interactions |
EXP |
pterostilbene inhibits the reaction [Ethanol results in increased expression of TERF1 protein] |
CTD |
PMID:34405320 |
|
NCBI chr 8:73,008,864...73,048,123
Ensembl chr 8:73,008,856...73,048,123
|
|
G |
TERT |
telomerase reverse transcriptase |
decreases expression multiple interactions |
EXP |
pterostilbene results in decreased expression of TERT mRNA; pterostilbene results in decreased expression of TERT protein pterostilbene inhibits the reaction [Ethanol results in decreased expression of TERT mRNA]; pterostilbene inhibits the reaction [Ethanol results in decreased expression of TERT protein]; Resveratrol promotes the reaction [pterostilbene results in decreased expression of TERT mRNA]; Resveratrol promotes the reaction [pterostilbene results in decreased expression of TERT protein] |
CTD |
PMID:26459286 PMID:34405320 |
|
NCBI chr 5:1,253,167...1,295,068
Ensembl chr 5:1,253,147...1,295,068
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP ISO |
MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]]; MAPK14 protein affects the reaction [pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ATF2 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of ELK1 protein modified form]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of IL1B mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of NOS2 protein]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 mRNA]; pterostilbene inhibits the reaction [[TNF protein co-treated with IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased expression of PTGS2 protein]; pterostilbene inhibits the reaction [Ethanol results in increased expression of TNF mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]; RIPK3 protein inhibits the reaction [pterostilbene inhibits the reaction [Ethanol results in increased expression of TNF mRNA]] pterostilbene inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of TNF mRNA]; pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; pterostilbene inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; SESN2 protein promotes the reaction [pterostilbene inhibits the reaction [Ethanol results in increased secretion of TNF protein]] |
CTD |
PMID:19549798 PMID:22698256 PMID:23731018 PMID:34405320 PMID:34474091 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TP53 |
tumor protein p53 |
increases expression |
EXP |
pterostilbene results in increased expression of TP53 mRNA |
CTD |
PMID:20152895 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TPT1 |
tumor protein, translationally-controlled 1 |
decreases expression |
EXP |
pterostilbene results in decreased expression of TPT1 protein |
CTD |
PMID:24936659 |
|
NCBI chr13:45,333,471...45,341,183
Ensembl chr13:45,333,471...45,341,284
|
|
G |
UGT1A1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation multiple interactions decreases activity |
EXP |
UGT1A1 protein results in increased glucuronidation of pterostilbene pterostilbene inhibits the reaction [[UGT1A1 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] pterostilbene results in decreased activity of UGT1A1 protein |
CTD |
PMID:23965644 PMID:31812603 |
|
NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
|
|
G |
UGT1A10 |
UDP glucuronosyltransferase family 1 member A10 |
affects glucuronidation |
EXP |
UGT1A10 protein affects the glucuronidation of pterostilbene |
CTD |
PMID:23965644 |
|
NCBI chr 2:233,636,448...233,773,300
Ensembl chr 2:233,636,448...233,773,300
|
|
G |
UGT1A3 |
UDP glucuronosyltransferase family 1 member A3 |
increases glucuronidation decreases activity multiple interactions |
EXP |
UGT1A3 protein results in increased glucuronidation of pterostilbene pterostilbene results in decreased activity of UGT1A3 protein pterostilbene inhibits the reaction [[UGT1A3 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] |
CTD |
PMID:23965644 PMID:31812603 |
|
NCBI chr 2:233,729,042...233,773,300
Ensembl chr 2:233,729,042...233,773,300
|
|
G |
UGT1A6 |
UDP glucuronosyltransferase family 1 member A6 |
decreases activity multiple interactions |
EXP |
pterostilbene results in decreased activity of UGT1A6 protein pterostilbene inhibits the reaction [[UGT1A6 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] |
CTD |
PMID:31812603 |
|
NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
|
|
G |
UGT1A8 |
UDP glucuronosyltransferase family 1 member A8 |
affects glucuronidation multiple interactions decreases activity |
EXP |
UGT1A8 protein affects the glucuronidation of pterostilbene pterostilbene inhibits the reaction [[UGT1A8 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] pterostilbene results in decreased activity of UGT1A8 protein |
CTD |
PMID:23965644 PMID:31812603 |
|
NCBI chr 2:233,617,633...233,773,300
Ensembl chr 2:233,617,633...233,773,300
|
|
G |
UGT1A9 |
UDP glucuronosyltransferase family 1 member A9 |
affects glucuronidation multiple interactions decreases activity |
EXP |
UGT1A9 protein affects the glucuronidation of pterostilbene pterostilbene inhibits the reaction [[UGT1A9 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] pterostilbene results in decreased activity of UGT1A9 protein |
CTD |
PMID:23965644 PMID:31812603 |
|
NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
|
|
G |
UGT2B15 |
UDP glucuronosyltransferase family 2 member B15 |
multiple interactions decreases activity |
EXP |
pterostilbene inhibits the reaction [[UGT2B15 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] pterostilbene results in decreased activity of UGT2B15 protein |
CTD |
PMID:31812603 |
|
NCBI chr 4:68,646,597...68,670,652
Ensembl chr 4:68,646,597...68,670,652
|
|
G |
UGT2B4 |
UDP glucuronosyltransferase family 2 member B4 |
multiple interactions decreases activity |
EXP |
pterostilbene inhibits the reaction [[UGT2B4 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] pterostilbene results in decreased activity of UGT2B4 protein |
CTD |
PMID:31812603 |
|
NCBI chr 4:69,480,165...69,526,014
Ensembl chr 4:69,480,165...69,526,014
|
|
G |
UGT2B7 |
UDP glucuronosyltransferase family 2 member B7 |
multiple interactions decreases activity |
EXP |
pterostilbene inhibits the reaction [[UGT2B7 protein results in increased metabolism of Hymecromone] which results in increased chemical synthesis of 4-methylumbelliferyl glucuronide] pterostilbene results in decreased activity of UGT2B7 protein |
CTD |
PMID:31812603 |
|
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
|
|
G |
UMOD |
uromodulin |
multiple interactions |
ISO |
pterostilbene inhibits the reaction [potassium oxonate results in increased expression of UMOD protein] |
CTD |
PMID:22865646 |
|
NCBI chr16:20,333,051...20,356,301
Ensembl chr16:20,333,051...20,356,301
|
|
G |
ZBED1 |
zinc finger BED-type containing 1 |
decreases expression |
EXP |
pterostilbene results in decreased expression of ZBED1 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr X:2,486,435...2,500,976 NCBI chr Y:2,486,435...2,500,976
Ensembl chr Y:2,486,414...2,500,976 Ensembl chr X:2,486,414...2,500,976
|
|
G |
ZNF488 |
zinc finger protein 488 |
decreases expression |
EXP |
pterostilbene results in decreased expression of ZNF488 mRNA |
CTD |
PMID:22450950 |
|
NCBI chr10:47,365,496...47,384,293
Ensembl chr10:47,365,496...47,384,293
|
|
|
G |
ESR1 |
estrogen receptor 1 |
increases activity |
EXP |
rhapontigenin analog results in increased activity of ESR1 protein |
CTD |
PMID:17935960 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
ESR2 |
estrogen receptor 2 |
increases activity multiple interactions |
EXP |
rhapontigenin analog results in increased activity of ESR2 protein Fulvestrant inhibits the reaction [rhapontigenin analog results in increased activity of ESR2 protein] |
CTD |
PMID:17692514 PMID:17935960 |
|
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
|
|
G |
TF |
transferrin |
multiple interactions |
EXP |
rhapontigenin analog inhibits the reaction [Lipopolysaccharides results in increased activity of TF protein] |
CTD |
PMID:16507316 |
|
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
|
|
|
G |
ABCB10 |
ATP binding cassette subfamily B member 10 |
decreases expression |
EXP |
pinosylvin results in decreased expression of ABCB10 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:229,516,582...229,558,707
Ensembl chr 1:229,516,582...229,558,707
|
|
G |
ABCE1 |
ATP binding cassette subfamily E member 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of ABCE1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:145,098,311...145,129,524
Ensembl chr 4:145,098,288...145,129,524
|
|
G |
ARHGAP29 |
Rho GTPase activating protein 29 |
decreases expression |
EXP |
pinosylvin results in decreased expression of ARHGAP29 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:94,168,905...94,314,592
Ensembl chr 1:94,148,988...94,275,068
|
|
G |
ART1 |
ADP-ribosyltransferase 1 |
increases expression |
EXP |
pinosylvin results in increased expression of ART1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr11:3,645,128...3,664,416
Ensembl chr11:3,645,128...3,664,416
|
|
G |
BAG2 |
BAG cochaperone 2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of BAG2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:57,172,326...57,189,833
Ensembl chr 6:57,172,326...57,189,833
|
|
G |
BCAP29 |
B cell receptor associated protein 29 |
decreases expression |
EXP |
pinosylvin results in decreased expression of BCAP29 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 7:107,580,007...107,623,317
Ensembl chr 7:107,580,246...107,629,170
|
|
G |
BIRC5 |
baculoviral IAP repeat containing 5 |
multiple interactions |
EXP |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
|
|
G |
BMP4 |
bone morphogenetic protein 4 |
multiple interactions |
EXP |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BMP4 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
|
|
G |
CBX3 |
chromobox 3 |
decreases expression |
EXP |
pinosylvin results in decreased expression of CBX3 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 7:26,201,443...26,213,607
Ensembl chr 7:26,201,162...26,213,607
|
|
G |
CCNA2 |
cyclin A2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of CCNA2 protein |
CTD |
PMID:23333577 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCND1 |
cyclin D1 |
multiple interactions decreases expression |
EXP |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of CCND1 mRNA pinosylvin results in decreased expression of CCND1 protein |
CTD |
PMID:23333577 |
|
NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
|
|
G |
CCNE1 |
cyclin E1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of CCNE1 protein |
CTD |
PMID:23333577 |
|
NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
|
|
G |
CDCA2 |
cell division cycle associated 2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of CDCA2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 8:25,458,931...25,507,917
Ensembl chr 8:25,459,199...25,507,911
|
|
G |
CDK2 |
cyclin dependent kinase 2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of CDK2 protein |
CTD |
PMID:23333577 |
|
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
|
|
G |
CDK2AP1 |
cyclin dependent kinase 2 associated protein 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of CDK2AP1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:123,260,976...123,272,240
Ensembl chr12:123,250,112...123,272,334
|
|
G |
CDK4 |
cyclin dependent kinase 4 |
decreases expression |
EXP |
pinosylvin results in decreased expression of CDK4 protein |
CTD |
PMID:23333577 |
|
NCBI chr12:57,747,727...57,752,310
Ensembl chr12:57,747,727...57,756,013
|
|
G |
CDK8 |
cyclin dependent kinase 8 |
decreases expression |
EXP |
pinosylvin results in decreased expression of CDK8 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr13:26,254,129...26,405,238
Ensembl chr13:26,254,104...26,420,982
|
|
G |
CDKN1A |
cyclin dependent kinase inhibitor 1A |
increases expression |
EXP |
pinosylvin results in increased expression of CDKN1A mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,397
|
|
G |
CENPF |
centromere protein F |
decreases expression |
EXP |
pinosylvin results in decreased expression of CENPF mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:214,603,195...214,664,571
Ensembl chr 1:214,603,185...214,664,574
|
|
G |
CEP290 |
centrosomal protein 290 |
increases expression |
EXP |
pinosylvin results in increased expression of CEP290 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:88,049,016...88,142,088
Ensembl chr12:88,049,016...88,142,099
|
|
G |
CHAF1B |
chromatin assembly factor 1 subunit B |
decreases expression |
EXP |
pinosylvin results in decreased expression of CHAF1B mRNA |
CTD |
PMID:23333577 |
|
NCBI chr21:36,385,392...36,419,015
Ensembl chr21:36,385,392...36,419,015
|
|
G |
CHD1 |
chromodomain helicase DNA binding protein 1 |
increases expression |
EXP |
pinosylvin results in increased expression of CHD1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 5:98,853,985...98,929,007
Ensembl chr 5:98,853,985...98,929,007
|
|
G |
CKS2 |
CDC28 protein kinase regulatory subunit 2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of CKS2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 9:89,311,195...89,316,703
Ensembl chr 9:89,311,195...89,316,703
|
|
G |
COX5A |
cytochrome c oxidase subunit 5A |
decreases expression |
EXP |
pinosylvin results in decreased expression of COX5A mRNA |
CTD |
PMID:23333577 |
|
NCBI chr15:74,919,791...74,938,073
Ensembl chr15:74,919,791...74,938,083
|
|
G |
COX7C |
cytochrome c oxidase subunit 7C |
decreases expression |
EXP |
pinosylvin results in decreased expression of COX7C mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 5:86,617,941...86,620,962
Ensembl chr 5:86,617,928...86,620,962
|
|
G |
CTNNB1 |
catenin beta 1 |
multiple interactions |
EXP |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BMP4 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of CCND1 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of ID2 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MMP7 mRNA; [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MYC mRNA; pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein |
CTD |
PMID:23333577 |
|
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
DCHS2 |
dachsous cadherin-related 2 |
increases expression |
EXP |
pinosylvin results in increased expression of DCHS2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:154,231,742...154,491,799
Ensembl chr 4:154,231,742...154,491,799
|
|
G |
DHX15 |
DEAH-box helicase 15 |
decreases expression |
EXP |
pinosylvin results in decreased expression of DHX15 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:24,527,475...24,584,554
Ensembl chr 4:24,517,441...24,584,554
|
|
G |
DLEU2 |
deleted in lymphocytic leukemia 2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of DLEU2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr13:49,982,549...50,125,541
Ensembl chr13:49,956,669...50,126,118
|
|
G |
DSG1 |
desmoglein 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of DSG1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr18:31,318,160...31,359,246
Ensembl chr18:31,318,160...31,359,246
|
|
G |
ENO1 |
enolase 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of ENO1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
|
|
G |
ERCC1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
increases expression |
EXP |
pinosylvin results in increased expression of ERCC1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
|
|
G |
ETFB |
electron transfer flavoprotein subunit beta |
increases expression |
EXP |
pinosylvin results in increased expression of ETFB mRNA |
CTD |
PMID:23333577 |
|
NCBI chr19:51,345,155...51,366,388
Ensembl chr19:51,345,169...51,366,388
|
|
G |
FBXO8 |
F-box protein 8 |
increases expression |
EXP |
pinosylvin results in increased expression of FBXO8 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:174,236,658...174,283,667
Ensembl chr 4:174,236,658...174,283,667
|
|
G |
FDPS |
farnesyl diphosphate synthase |
decreases expression |
EXP |
pinosylvin results in decreased expression of FDPS mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:155,308,866...155,320,665
Ensembl chr 1:155,308,748...155,320,666
|
|
G |
FH |
fumarate hydratase |
decreases expression |
EXP |
pinosylvin results in decreased expression of FH mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:241,497,603...241,519,755
Ensembl chr 1:241,497,511...241,519,799
|
|
G |
FTH1 |
ferritin heavy chain 1 |
increases expression |
EXP |
pinosylvin results in increased expression of FTH1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr11:61,964,285...61,967,634
Ensembl chr11:61,959,718...61,967,634
|
|
G |
GADD45A |
growth arrest and DNA damage inducible alpha |
increases expression |
EXP |
pinosylvin results in increased expression of GADD45A mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
|
|
G |
GDF15 |
growth differentiation factor 15 |
increases expression |
EXP |
pinosylvin results in increased expression of GDF15 mRNA; pinosylvin results in increased expression of GDF15 protein |
CTD |
PMID:23333577 |
|
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
|
|
G |
GNAI1 |
G protein subunit alpha i1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of GNAI1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 7:80,134,831...80,226,181
Ensembl chr 7:79,768,028...80,226,181
|
|
G |
GTF2H5 |
general transcription factor IIH subunit 5 |
decreases expression |
EXP |
pinosylvin results in decreased expression of GTF2H5 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:158,168,350...158,199,344
Ensembl chr 6:158,168,350...158,199,344
|
|
G |
H3-3B |
H3.3 histone B |
decreases expression |
EXP |
pinosylvin results in decreased expression of H3-3B mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:75,776,434...75,779,779
Ensembl chr17:75,776,434...75,785,893
|
|
G |
HAL |
histidine ammonia-lyase |
increases expression |
EXP |
pinosylvin results in increased expression of HAL mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:95,972,662...95,996,344
Ensembl chr12:95,972,662...95,996,365
|
|
G |
HMOX2 |
heme oxygenase 2 |
increases expression |
EXP |
pinosylvin results in increased expression of HMOX2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr16:4,474,736...4,510,347
Ensembl chr16:4,474,690...4,510,347
|
|
G |
HSP90AB1 |
heat shock protein 90 alpha family class B member 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of HSP90AB1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:44,246,194...44,253,883
Ensembl chr 6:44,246,166...44,253,888
|
|
G |
ID2 |
inhibitor of DNA binding 2 |
multiple interactions decreases expression |
EXP |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of ID2 mRNA pinosylvin results in decreased expression of ID2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
|
|
G |
IDI1 |
isopentenyl-diphosphate delta isomerase 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of IDI1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
|
|
G |
IL1RAP |
interleukin 1 receptor accessory protein |
decreases expression |
EXP |
pinosylvin results in decreased expression of IL1RAP mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 3:190,514,085...190,659,750
Ensembl chr 3:190,514,051...190,659,750
|
|
G |
IRF2BP1 |
interferon regulatory factor 2 binding protein 1 |
increases expression |
EXP |
pinosylvin results in increased expression of IRF2BP1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr19:45,883,608...45,886,141
Ensembl chr19:45,883,608...45,886,141
|
|
G |
JAG1 |
jagged canonical Notch ligand 1 |
increases expression |
EXP |
pinosylvin results in increased expression of JAG1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
|
|
G |
KBTBD6 |
kelch repeat and BTB domain containing 6 |
decreases expression |
EXP |
pinosylvin results in decreased expression of KBTBD6 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr13:41,127,569...41,132,802
Ensembl chr13:41,127,569...41,132,802
|
|
G |
LRRC25 |
leucine rich repeat containing 25 |
increases expression |
EXP |
pinosylvin results in increased expression of LRRC25 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr19:18,391,137...18,397,622
Ensembl chr19:18,391,137...18,397,622
|
|
G |
LSM6 |
LSM6 homolog, U6 small nuclear RNA and mRNA degradation associated |
decreases expression |
EXP |
pinosylvin results in decreased expression of LSM6 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:146,175,718...146,191,535
Ensembl chr 4:146,175,703...146,200,000
|
|
G |
MCM5 |
minichromosome maintenance complex component 5 |
decreases expression |
EXP |
pinosylvin results in decreased expression of MCM5 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr22:35,400,140...35,455,031
Ensembl chr22:35,400,134...35,425,431
|
|
G |
METAP2 |
methionyl aminopeptidase 2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of METAP2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:95,474,152...95,515,839
Ensembl chr12:95,473,520...95,515,839
|
|
G |
MEX3D |
mex-3 RNA binding family member D |
decreases expression |
EXP |
pinosylvin results in decreased expression of MEX3D mRNA |
CTD |
PMID:23333577 |
|
NCBI chr19:1,554,672...1,568,325
Ensembl chr19:1,554,672...1,568,325
|
|
G |
MMP7 |
matrix metallopeptidase 7 |
multiple interactions |
EXP |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MMP7 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr11:102,520,508...102,530,747
Ensembl chr11:102,520,508...102,530,750
|
|
G |
MRPL14 |
mitochondrial ribosomal protein L14 |
decreases expression |
EXP |
pinosylvin results in decreased expression of MRPL14 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:44,113,451...44,127,452
Ensembl chr 6:44,113,451...44,127,452
|
|
G |
MRPL41 |
mitochondrial ribosomal protein L41 |
decreases expression |
EXP |
pinosylvin results in decreased expression of MRPL41 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 9:137,551,879...137,552,555
Ensembl chr 9:137,551,879...137,552,555
|
|
G |
MT4 |
metallothionein 4 |
increases expression |
EXP |
pinosylvin results in increased expression of MT4 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr16:56,565,073...56,568,957
Ensembl chr16:56,565,073...56,568,957
|
|
G |
MYC |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions decreases expression |
EXP |
[pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of MYC mRNA pinosylvin results in decreased expression of MYC protein |
CTD |
PMID:23333577 |
|
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
|
|
G |
NUP35 |
nucleoporin 35 |
decreases expression |
EXP |
pinosylvin results in decreased expression of NUP35 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:183,117,514...183,161,680
Ensembl chr 2:183,117,513...183,161,680
|
|
G |
OAZ1 |
ornithine decarboxylase antizyme 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of OAZ1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr19:2,269,486...2,273,488
Ensembl chr19:2,269,509...2,273,492
|
|
G |
PCNA |
proliferating cell nuclear antigen |
decreases expression |
EXP |
pinosylvin results in decreased expression of PCNA mRNA |
CTD |
PMID:23333577 |
|
NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
|
|
G |
POLR2J |
RNA polymerase II subunit J |
increases expression |
EXP |
pinosylvin results in increased expression of POLR2J mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 7:102,473,128...102,478,922
Ensembl chr 7:102,473,128...102,478,922
|
|
G |
PPAT |
phosphoribosyl pyrophosphate amidotransferase |
decreases expression |
EXP |
pinosylvin results in decreased expression of PPAT mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:56,393,362...56,435,615
Ensembl chr 4:56,393,362...56,435,615
|
|
G |
PTGES2 |
prostaglandin E synthase 2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of PTGES2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 9:128,120,693...128,128,440
Ensembl chr 9:128,120,693...128,128,462
|
|
G |
PTK2 |
protein tyrosine kinase 2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of PTK2 protein modified form |
CTD |
PMID:23333577 |
|
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
|
|
G |
PXMP4 |
peroxisomal membrane protein 4 |
increases expression |
EXP |
pinosylvin results in increased expression of PXMP4 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr20:33,702,758...33,720,310
Ensembl chr20:33,702,758...33,720,319
|
|
G |
RAD23B |
RAD23 homolog B, nucleotide excision repair protein |
decreases expression |
EXP |
pinosylvin results in decreased expression of RAD23B mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 9:107,283,279...107,332,194
Ensembl chr 9:107,283,137...107,332,192
|
|
G |
RB1 |
RB transcriptional corepressor 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of RB1 protein |
CTD |
PMID:23333577 |
|
NCBI chr13:48,303,751...48,481,890
Ensembl chr13:48,303,744...48,599,436
|
|
G |
RBBP8 |
RB binding protein 8, endonuclease |
decreases expression |
EXP |
pinosylvin results in decreased expression of RBBP8 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr18:22,914,139...23,026,486
Ensembl chr18:22,798,261...23,026,488
|
|
G |
RBX1 |
ring-box 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of RBX1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr22:40,951,378...40,973,309
Ensembl chr22:40,951,347...40,973,309
|
|
G |
RRM2 |
ribonucleotide reductase regulatory subunit M2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of RRM2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725
|
|
G |
SEC22B |
SEC22 homolog B, vesicle trafficking protein |
increases expression |
EXP |
pinosylvin results in increased expression of SEC22B mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:120,150,898...120,176,520
Ensembl chr 1:120,150,898...120,176,520
|
|
G |
SERBP1 |
SERPINE1 mRNA binding protein 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of SERBP1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:67,407,810...67,430,402
Ensembl chr 1:67,407,810...67,430,415
|
|
G |
SGTA |
small glutamine rich tetratricopeptide repeat co-chaperone alpha |
increases expression |
EXP |
pinosylvin results in increased expression of SGTA mRNA |
CTD |
PMID:23333577 |
|
NCBI chr19:2,754,715...2,783,273
Ensembl chr19:2,754,715...2,783,362
|
|
G |
SLC38A2 |
solute carrier family 38 member 2 |
increases expression |
EXP |
pinosylvin results in increased expression of SLC38A2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:46,358,188...46,372,773
Ensembl chr12:46,358,188...46,372,773
|
|
G |
SNRPB2 |
small nuclear ribonucleoprotein polypeptide B2 |
decreases expression |
EXP |
pinosylvin results in decreased expression of SNRPB2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr20:16,730,026...16,742,564
Ensembl chr20:16,729,961...16,742,564
|
|
G |
SNRPG |
small nuclear ribonucleoprotein polypeptide G |
decreases expression |
EXP |
pinosylvin results in decreased expression of SNRPG mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:70,281,362...70,293,740
Ensembl chr 2:70,281,362...70,293,740
|
|
G |
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
decreases expression |
EXP |
pinosylvin results in decreased expression of SRC protein modified form |
CTD |
PMID:23333577 |
|
NCBI chr20:37,344,699...37,406,050
Ensembl chr20:37,344,685...37,406,050
|
|
G |
SRSF10 |
serine and arginine rich splicing factor 10 |
decreases expression |
EXP |
pinosylvin results in decreased expression of SRSF10 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:23,964,347...23,980,327
Ensembl chr 1:23,964,347...23,980,927
|
|
G |
SRSF11 |
serine and arginine rich splicing factor 11 |
decreases expression |
EXP |
pinosylvin results in decreased expression of SRSF11 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:70,205,696...70,253,052
Ensembl chr 1:70,205,682...70,253,052
|
|
G |
SRSF3 |
serine and arginine rich splicing factor 3 |
decreases expression |
EXP |
pinosylvin results in decreased expression of SFRS3 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:36,594,362...36,605,600
Ensembl chr 6:36,594,353...36,605,911
|
|
G |
SSBP1 |
single stranded DNA binding protein 1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of SSBP1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 7:141,738,321...141,750,488
Ensembl chr 7:141,738,334...141,787,922
|
|
G |
STX6 |
syntaxin 6 |
increases expression |
EXP |
pinosylvin results in increased expression of STX6 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 1:180,972,725...181,022,870
Ensembl chr 1:180,972,712...181,023,121
|
|
G |
TBC1D25 |
TBC1 domain family member 25 |
increases expression |
EXP |
pinosylvin results in increased expression of TBC1D25 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr X:48,539,714...48,562,609
Ensembl chr X:48,539,714...48,562,609
|
|
G |
TIMM13 |
translocase of inner mitochondrial membrane 13 |
decreases expression |
EXP |
pinosylvin results in decreased expression of TIMM13 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr19:2,425,625...2,427,586
Ensembl chr19:2,425,625...2,427,586
|
|
G |
TMED2 |
transmembrane p24 trafficking protein 2 |
increases expression |
EXP |
pinosylvin results in increased expression of TMED2 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:123,584,552...123,598,582
Ensembl chr12:123,584,533...123,598,582
|
|
G |
TMPRSS3 |
transmembrane serine protease 3 |
decreases expression |
EXP |
pinosylvin results in decreased expression of TMPRSS3 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr21:42,371,890...42,396,052
Ensembl chr21:42,371,887...42,396,091
|
|
G |
TNRC6C |
trinucleotide repeat containing adaptor 6C |
decreases expression |
EXP |
pinosylvin results in decreased expression of TNRC6C mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:77,957,557...78,108,835
Ensembl chr17:77,958,703...78,108,822
|
|
G |
TP53 |
tumor protein p53 |
increases expression |
EXP |
pinosylvin results in increased expression of TP53 protein |
CTD |
PMID:23333577 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
|
|
G |
TSC22D1 |
TSC22 domain family member 1 |
increases expression |
EXP |
pinosylvin results in increased expression of TSC22D1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr13:44,432,143...44,577,344
Ensembl chr13:44,432,143...44,577,147
|
|
G |
TUBA1B |
tubulin alpha 1b |
decreases expression |
EXP |
pinosylvin results in decreased expression of TUBA1B mRNA |
CTD |
PMID:23333577 |
|
NCBI chr12:49,127,782...49,131,395
Ensembl chr12:49,127,782...49,131,397
|
|
G |
TUBB |
tubulin beta class I |
decreases expression |
EXP |
pinosylvin results in decreased expression of TUBB mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 6:30,720,352...30,725,422
Ensembl chr 6:30,717,435...30,725,538
|
|
G |
UBE2D1 |
ubiquitin conjugating enzyme E2 D1 |
decreases expression |
EXP |
pinosylvin results in decreased expression of UBE2D1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr10:58,335,006...58,370,748
Ensembl chr10:58,334,979...58,370,751
|
|
G |
UBXN2A |
UBX domain protein 2A |
decreases expression |
EXP |
pinosylvin results in decreased expression of UBXN2A mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 2:23,927,278...24,004,909
Ensembl chr 2:23,927,285...24,004,909
|
|
G |
UCHL1 |
ubiquitin C-terminal hydrolase L1 |
increases expression |
EXP |
pinosylvin results in increased expression of UCHL1 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:41,256,928...41,268,455
Ensembl chr 4:41,256,413...41,268,455
|
|
G |
USP22 |
ubiquitin specific peptidase 22 |
decreases expression |
EXP |
pinosylvin results in decreased expression of USP22 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:20,999,596...21,043,419
Ensembl chr17:20,999,596...21,043,760
|
|
G |
USP7 |
ubiquitin specific peptidase 7 |
increases expression |
EXP |
pinosylvin results in increased expression of USP7 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr16:8,892,097...8,963,906
Ensembl chr16:8,892,097...8,975,328
|
|
G |
ZBTB44 |
zinc finger and BTB domain containing 44 |
decreases expression |
EXP |
pinosylvin results in decreased expression of ZBTB44 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr11:130,226,677...130,314,917
Ensembl chr11:130,226,677...130,314,917
|
|
G |
ZNF100 |
zinc finger protein 100 |
decreases expression |
EXP |
pinosylvin results in decreased expression of ZNF100 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr19:21,722,771...21,767,579
Ensembl chr19:21,722,771...21,767,579
|
|
G |
ZNF207 |
zinc finger protein 207 |
decreases expression |
EXP |
pinosylvin results in decreased expression of ZNF207 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr17:32,350,157...32,381,885
Ensembl chr17:32,350,132...32,381,885
|
|
G |
ZNF330 |
zinc finger protein 330 |
decreases expression |
EXP |
pinosylvin results in decreased expression of ZNF330 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 4:141,220,535...141,234,697
Ensembl chr 4:141,220,887...141,234,697
|
|
G |
ZNF92 |
zinc finger protein 92 |
decreases expression |
EXP |
pinosylvin results in decreased expression of ZNF92 mRNA |
CTD |
PMID:23333577 |
|
NCBI chr 7:65,373,855...65,401,136
Ensembl chr 7:65,373,799...65,401,136
|
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased activity of CAT protein] |
CTD |
PMID:32662907 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of HMOX1 mRNA]; rhapontin inhibits the reaction [Streptozocin results in decreased expression of HMOX1 protein] |
CTD |
PMID:32662907 |
|
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
|
|
G |
IL10 |
interleukin 10 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of IL10 mRNA]; rhapontin inhibits the reaction [Streptozocin results in decreased expression of IL10 protein] |
CTD |
PMID:32662907 |
|
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
|
|
G |
INS-IGF2 |
INS-IGF2 readthrough |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] |
CTD |
PMID:32662907 |
|
NCBI chr11:2,129,117...2,161,209
Ensembl chr11:2,132,538...2,161,209
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in increased expression of KEAP1 mRNA]; rhapontin inhibits the reaction [Streptozocin results in increased expression of KEAP1 protein] |
CTD |
PMID:32662907 |
|
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in increased expression of MMP2 mRNA] |
CTD |
PMID:32662907 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 mRNA]; rhapontin inhibits the reaction [Streptozocin results in decreased expression of NFE2L2 protein] |
CTD |
PMID:32662907 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of NQO1 mRNA] |
CTD |
PMID:32662907 |
|
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in decreased expression of TIMP1 mRNA] |
CTD |
PMID:32662907 |
|
NCBI chr X:47,582,436...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
rhapontin inhibits the reaction [Streptozocin results in increased expression of TNF mRNA] |
CTD |
PMID:32662907 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
|
G |
AR |
androgen receptor |
affects binding |
ISO |
4,4'-dihydroxystilbene binds to AR protein |
CTD |
PMID:14565775 |
|
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
|
|
G |
CCNA2 |
cyclin A2 |
increases expression |
EXP |
4,4'-dihydroxystilbene results in increased expression of CCNA2 mRNA |
CTD |
PMID:19496085 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CTSD |
cathepsin D |
increases expression |
EXP |
4,4'-dihydroxystilbene results in increased expression of CTSD mRNA |
CTD |
PMID:19496085 |
|
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
|
|
G |
ECE1 |
endothelin converting enzyme 1 |
decreases activity decreases expression |
EXP |
4,4'-dihydroxystilbene results in decreased activity of ECE1 protein 4,4'-dihydroxystilbene results in decreased expression of ECE1 mRNA |
CTD |
PMID:21554123 |
|
NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572
|
|
G |
EDN1 |
endothelin 1 |
decreases secretion decreases expression |
EXP |
4,4'-dihydroxystilbene results in decreased secretion of EDN1 protein 4,4'-dihydroxystilbene results in decreased expression of EDN1 mRNA |
CTD |
PMID:21554123 |
|
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions |
EXP |
4,4'-dihydroxystilbene analog binds to and results in increased activity of ESR1 protein; fulvestrant inhibits the reaction [4,4'-dihydroxystilbene analog binds to and results in increased activity of ESR1 protein] |
CTD |
PMID:19496085 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
4,4'-dihydroxystilbene results in increased expression of FOS mRNA |
CTD |
PMID:19496085 |
|
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
|
|
G |
PGR |
progesterone receptor |
increases expression |
EXP |
4,4'-dihydroxystilbene results in increased expression of PGR mRNA |
CTD |
PMID:19496085 |
|
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
|
|
G |
SHBG |
sex hormone binding globulin |
affects binding |
EXP |
4,4'-dihydroxystilbene binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr17:7,614,064...7,633,372
Ensembl chr17:7,613,946...7,633,382
|
|
G |
TFF1 |
trefoil factor 1 |
increases expression |
EXP |
4,4'-dihydroxystilbene results in increased expression of TFF1 mRNA |
CTD |
PMID:19496085 |
|
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
|
|